1. Home
  2. EQV vs BBNX Comparison

EQV vs BBNX Comparison

Compare EQV & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQV
  • BBNX
  • Stock Information
  • Founded
  • EQV 2024
  • BBNX 2015
  • Country
  • EQV United States
  • BBNX United States
  • Employees
  • EQV N/A
  • BBNX N/A
  • Industry
  • EQV
  • BBNX Medical/Dental Instruments
  • Sector
  • EQV
  • BBNX Health Care
  • Exchange
  • EQV Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • EQV 449.7M
  • BBNX 435.7M
  • IPO Year
  • EQV 2024
  • BBNX 2025
  • Fundamental
  • Price
  • EQV $10.23
  • BBNX $13.95
  • Analyst Decision
  • EQV
  • BBNX Strong Buy
  • Analyst Count
  • EQV 0
  • BBNX 6
  • Target Price
  • EQV N/A
  • BBNX $26.67
  • AVG Volume (30 Days)
  • EQV 163.7K
  • BBNX 411.0K
  • Earning Date
  • EQV 01-01-0001
  • BBNX 05-06-2025
  • Dividend Yield
  • EQV N/A
  • BBNX N/A
  • EPS Growth
  • EQV N/A
  • BBNX N/A
  • EPS
  • EQV N/A
  • BBNX N/A
  • Revenue
  • EQV N/A
  • BBNX $69,830,000.00
  • Revenue This Year
  • EQV N/A
  • BBNX $29.49
  • Revenue Next Year
  • EQV N/A
  • BBNX $34.93
  • P/E Ratio
  • EQV $49.93
  • BBNX N/A
  • Revenue Growth
  • EQV N/A
  • BBNX 38911.17
  • 52 Week Low
  • EQV $9.88
  • BBNX $8.89
  • 52 Week High
  • EQV $10.25
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • EQV N/A
  • BBNX N/A
  • Support Level
  • EQV N/A
  • BBNX N/A
  • Resistance Level
  • EQV N/A
  • BBNX N/A
  • Average True Range (ATR)
  • EQV 0.00
  • BBNX 0.00
  • MACD
  • EQV 0.00
  • BBNX 0.00
  • Stochastic Oscillator
  • EQV 0.00
  • BBNX 0.00

About EQV EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp is a blank check company.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: